RGNX REGENXBIO Inc. - Common Stock
NASDAQ · Biotechnology · Voir sur SEC EDGAR ↗ clôture Oct 2, 2026 10-K/10-Q Aoû 6, 2026
$7,43
· % de la fourchette 52 sem.
· au-dessus du plus bas
· vers le haut
$5,46Bas 52 semaines
$16,00Haut 52 semaines
Capitalisation Boursière (MRQ)
$402M
P/E (TTM)
-2.0
BPA (TTM)
$-3.79
Revenu (TTM)
$174M
vos badges
Fourchette 52 semaines
$5–$16
Note des analystes
BUY
Objectif de cours
$24
P/E
-2.0
ROE
-137.6%
Marge nette
-112.6%
Votre barre de badges est vide — épinglez une métrique n'importe où sur cette page.
RGNX Aperçu de l'action Prix, capitalisation boursière, P/E, EPS, ROE, dette/capitaux propres, fourchette sur 52 semaines
Prix
$7.43
Capitalisation Boursière (MRQ)
$402M
P/E (TTM)
-2.0
BPA (TTM)
$-3.79
Revenu (TTM)
$174M
ROE (TTM)
-137.6%
Fourchette 52 semaines
$5–$16
RGNX Graphique du cours de l'action OHLCV quotidien avec indicateurs techniques — panoramique, zoom et personnalisez votre vue
fourchette
barres
La granularité des barres s'adapte à la période sélectionnée — survolez le graphique pour voir l'ouverture/le maximum/le minimum/la clôture d'une barre.
Performance sur 10 ans Tendances du chiffre d'affaires, du bénéfice net, des marges et du BPA
Revenu$170M2016-12-31 → 2025-12-31
BPA$-3.762016-12-31 → 2025-12-31
Flux de trésorerie libre$-126M2016-12-31 → 2025-12-31
Marge nette-112.6%2016-12-31 → 2025-12-31
Valorisation et Ratios
Valorisation Ratios P/E, P/S, P/B, EV/EBITDA — l'action est-elle chère ou bon marché ?
| Métrique | Tendance sur 5 ans | RGNX | moyenne 5 ans | Médiane des pairs | Verdict |
|---|---|---|---|---|---|
| P/E (TTM) | -2.0moyenne 5 ans ≈-0.1 | ≈-0.1 | · | · | |
| P/S (TTM) | 2.3moyenne 5 ans ≈5.9 | ≈5.9 | 3.7 | Juste valeur | |
| P/B (MRQ) | 5.6moyenne 5 ans ≈3.0 | ≈3.0 | 3.0 | Surévalué | |
| Cours / FCF (TTM) | -1.6moyenne 5 ans ≈-1.0 | ≈-1.0 | · | · | |
| Cours / Flux de trésorerie (TTM) | -1.6moyenne 5 ans ≈-2.0 | ≈-2.0 | · | · | |
| Price / Tangible Book (Cours / Actif net tangible) | 3.7moyenne 5 ans ≈3.0 | ≈3.0 | · | · |
La médiane des pairs est calculée sur une base standardisée par métrique et peut ne pas toujours correspondre à la base TTM/MRQ indiquée pour cette action.
Rentabilité Marges brutes, d'exploitation et nettes ; ROE, ROA, ROIC
| Métrique | Tendance sur 5 ans | RGNX | moyenne 5 ans | Médiane des pairs | Verdict |
|---|---|---|---|---|---|
| Marge d'exploitation (TTM) | -94.1%moyenne 5 ans ≈-174.2% | ≈-174.2% | -47.4% | Premier rang | |
| EBITDA Margin (Marge EBITDA) | -94.6%moyenne 5 ans ≈-174.2% | ≈-174.2% | -47.4% | Premier rang | |
| Pretax Margin (Marge avant impôts) | -113.8%moyenne 5 ans ≈-179.4% | ≈-179.4% | -61.1% | Inférieur à la moyenne | |
| Marge nette (TTM) | -112.6%moyenne 5 ans ≈-180.0% | ≈-180.0% | -28.8% | Premier rang | |
| ROA (TTM) | -40.6%moyenne 5 ans ≈-27.6% | ≈-27.6% | -14.3% | Faible | |
| ROE (TTM) | -137.6%moyenne 5 ans ≈-62.5% | ≈-62.5% | -14.4% | Faible | |
| ROIC | -156.9%moyenne 5 ans ≈-68.7% | ≈-68.7% | -12.1% | Faible |
Santé financière Dette, liquidité, solvabilité — solidité du bilan
| Métrique | Tendance sur 5 ans | RGNX | moyenne 5 ans | Médiane des pairs | Verdict |
|---|---|---|---|---|---|
| Ratio de liquidité (MRQ) | 2.9moyenne 5 ans ≈3.0 | ≈3.0 | 10.4 | Faible liquidité | |
| Ratio de liquidité réduite (MRQ) | 2.6moyenne 5 ans ≈2.7 | ≈2.7 | 2.9 | En ligne |
Croissance Croissance du chiffre d'affaires, du BPA et du bénéfice net : Année/Année, TCAC 3 ans, TCAC 5 ans
| Métrique | Tendance sur 5 ans | RGNX | moyenne 5 ans | Médiane des pairs | Verdict |
|---|---|---|---|---|---|
| Revenue YoY (Chiffre d'affaires YoY) | 104.5%moyenne 5 ans ≈41.0% | ≈41.0% | · | · | |
| Revenue CAGR 3Y (CAGR du chiffre d'affaires 3 ans) | 14.8%moyenne 5 ans ≈-15.2% | ≈-15.2% | · | · | |
| Revenue CAGR 5Y (CAGR du chiffre d'affaires 5 ans) | 2.0% | · | · | · |
Efficacité du capital Rotation des actifs, rotation des stocks, rotation des créances
| Métrique | Tendance sur 5 ans | RGNX | moyenne 5 ans | Médiane des pairs | Verdict |
|---|---|---|---|---|---|
| Asset Turnover (Rotation des actifs) | 0.4moyenne 5 ans ≈0.3 | ≈0.3 | 0.4 | En ligne | |
| Receivables Turnover (Rotation des créances) | 7.3moyenne 5 ans ≈6.1 | ≈6.1 | 54.7 | Faible | |
| Revenue / Employee (Chiffre d'affaires annuel ÷ employés (effectif déclaré, yfinance). Dérivé — pas un concept SEC-XBRL stocké.) | ≈$459.4K | · | · | · |
valeur · ≈ moyenne 5 ans · médiane du secteur · verdict par rapport à la médiane
Historique des bénéfices BPA réel vs estimation, surprise %, taux de succès, prochaine date de publication des résultats
Surprise Moyenne
79.7%
Prochain rapport
Nov 04, 2026
| Période | Rapport | EPS Actual | BPA est. | Surprise |
|---|---|---|---|---|
| 30 juin 2026 | Aoû 5, 2026 | $0.43 | $0.06 | 626.4% |
| 31 mars 2026 | Mai 14, 2026 | $-1.72 | $-1.37 | -25.9% |
| 31 décembre 2025 | $-1.30 | $-0.98 | -33.3% | |
| 30 septembre 2025 | $-1.20 | $-1.33 | 9.9% | |
| 30 juin 2025 | $-1.38 | $-1.12 | -23.0% | |
| 31 mars 2025 | $0.12 | $0.49 | -75.6% |
Fondamentaux complets Tous les indicateurs par an — compte de résultat, bilan, flux de trésorerie
Compte de résultat
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $170M | $83M | $90M | $113M | $470M | $155M | $35M | $219M | $10M | $5M | $8M | $6M | |
| Cost of Revenue | · | $34M | $37M | $55M | $52M | $36M | $8M | $10M | $2M | $98.0K | $98.0K | $122.0K | |
| R&D Expense | $228M | $209M | $232M | $242M | $181M | $166M | $124M | $84M | $57M | $45M | $17M | $5M | |
| SG&A Expense | $83M | $77M | $88M | $85M | $79M | $64M | $52M | $37M | $27M | $24M | $12M | $4M | |
| Operating Expenses | $332M | $317M | $358M | $376M | $310M | $274M | $184M | $130M | $86M | $70M | $31M | $10M | |
| Operating Income | $-161M | $-233M | $-268M | $-263M | $160M | $-119M | $-149M | $88M | $-76M | $-65M | $-23M | $-4M | |
| Interest Expense | · | · | $7M | $23M | $26M | $771.0K | · | · | · | · | $20.0K | $321.0K | |
| Interest Income | $12M | $12M | $9M | $6M | · | · | · | · | · | · | · | · | |
| Other Non-op | $-33M | $6M | $4M | $-18M | $-19M | $13M | $52M | $16M | $3M | $2M | $326.0K | $-321.0K | |
| Pretax Income | $-194M | $-227M | $-264M | $-280M | $141M | $-106M | $-97M | $104M | $-73M | $-63M | $-23M | $-4M | |
| Income Tax | $0 | $0 | $-152.0K | $-84.0K | $13M | $5M | $-3M | $4M | $0 | $-435.0K | $0 | $0 | |
| Net Income | $-194M | $-227M | $-263M | $-280M | $128M | $-111M | $-95M | $100M | $-73M | $-63M | $-23M | $-4M | |
| EPS (Basic) | $-3.76 | $-4.59 | $-6.02 | $-6.50 | $3.01 | $-2.98 | $-2.58 | $2.99 | $-2.45 | $-2.38 | · | · | |
| EPS (Diluted) | $-3.76 | $-4.59 | $-6.02 | $-6.50 | $2.91 | $-2.98 | $-2.58 | $2.73 | $-2.45 | $-2.38 | · | · | |
| Shares (Basic) | 51,573,000 | 49,509,000 | 43,734,000 | 43,152,000 | 42,438,000 | 37,281,000 | 36,690,000 | 33,427,000 | 29,878,000 | 26,409,000 | · | · | |
| Shares (Diluted) | 51,573,000 | 49,509,000 | 43,734,000 | 43,152,000 | 43,913,000 | 37,281,000 | 36,690,000 | 36,648,000 | 29,878,000 | 26,409,000 | · | · | |
| EBITDA | $-161M | $-233M | $-268M | $-263M | $160M | $-119M | $-149M | $88M | $-76M | $-65M | $-23M | · |
Bilan
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $34M | $58M | $35M | $97M | $345M | $338M | $70M | $76M | $47M | $25M | $54M | $1M | |
| Short-term Investments | $196M | $177M | $241M | $268M | $112M | $137M | $227M | $244M | $114M | $65M | $60M | · | |
| Receivables | $26M | $20M | $25M | $28M | $32M | $43M | $38M | · | · | · | $2M | $805.0K | |
| Prepaid Expense | $12M | $9M | $15M | $14M | $19M | $11M | $6M | $6M | $5M | $2M | $1M | $28.0K | |
| Other Current Assets | $13M | $14M | $20M | $9M | $10M | $2M | $4M | $4M | $1M | $1M | $851.0K | · | |
| Current Assets | $281M | $278M | $335M | $416M | $519M | $531M | $345M | $338M | $168M | $93M | $118M | $3M | |
| PP&E (Net) | $105M | $118M | $132M | $142M | $132M | $56M | $29M | $29M | $14M | $9M | $538.0K | $0 | |
| PP&E (Gross) | $192M | $190M | $189M | $183M | $161M | $79M | $43M | $36M | $17M | $10M | $618.0K | · | |
| Accum. Depreciation | $87M | $72M | $57M | $41M | $29M | $23M | $14M | $7M | $3M | $624.0K | $80.0K | · | |
| Other Non-current Assets | $5M | $4M | $5M | $6M | $6M | $5M | $5M | $2M | $862.0K | $400.0K | $168.0K | · | |
| Total Assets | $453M | $466M | $574M | $833M | $1.11B | $708M | $498M | $544M | $199M | $173M | $221M | $3M | |
| Accounts Payable | $21M | $23M | $23M | $27M | $11M | $11M | $6M | $4M | $5M | $2M | $1M | $334.0K | |
| Accrued Liabilities | · | · | · | · | · | · | · | · | · | · | · | $1M | |
| Current Liabilities | $118M | $103M | $130M | $130M | $130M | $81M | $34M | $22M | $14M | $10M | $4M | $9M | |
| Capital Leases | $65M | $74M | $82M | $89M | $85M | $70M | $9M | · | · | · | · | · | |
| Other Non-current Liabilities | $638.0K | $4M | $6M | $9M | $745.0K | $524.0K | $2M | $3M | · | · | · | · | |
| Total Liabilities | $350M | $206M | $262M | $317M | $350M | $330M | $48M | $35M | $16M | $11M | $5M | $9M | |
| Common Stock | $5.0K | $5.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $3.0K | $3.0K | $3.0K | · | |
| Retained Earnings | $-1.13B | $-932M | $-705M | $-442M | $-161M | $-289M | $-178M | $-83M | $-188M | $-115M | $-52M | $-29M | |
| AOCI | $-687.0K | $-741.0K | $-4M | $-15M | $-3M | $-360.0K | $205.0K | $-720.0K | $-715.0K | $-33.0K | $-719.0K | · | |
| Stockholders' Equity | $103M | $260M | $312M | $516M | $764M | $378M | $450M | $509M | $183M | $162M | $217M | $-18M | |
| Liabilities + Equity | $453M | $466M | $574M | $833M | $1.11B | $708M | $498M | $544M | $199M | $173M | $221M | $3M | |
| Shares Outstanding | 50,892,000 | 49,549,000 | 44,046,000 | 43,299,000 | 42,831,000 | 37,476,000 | 36,992,000 | 36,120,000 | 31,295,000 | 26,477,000 | 26,313,000 | 2,645,000 |
Flux de trésorerie
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $16M | $16M | $17M | $13M | $10M | $8M | $7M | $4M | $3M | $544.0K | $80.0K | $0 | |
| Stock-based Comp | $35M | $38M | $40M | $41M | $39M | $32M | $27M | $17M | $11M | $7M | $3M | $319.0K | |
| Deferred Tax | · | · | · | · | · | · | $-467.0K | · | · | $-435.0K | · | · | |
| Restructuring | $0 | $0 | $4M | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-124M | $-173M | $-218M | $-207M | $219M | $-54M | $-108M | $105M | $-58M | $-49M | $-23M | $-2M | |
| CapEx | $2M | $2M | $10M | $31M | $84M | $27M | $12M | $13M | $7M | $8M | $522.0K | · | |
| Investing Cash Flow | $-16M | $103M | $191M | $-12M | $-407M | $123M | $94M | $-279M | $-5M | $19M | · | · | |
| Stock Issued | · | · | · | · | · | · | · | $190M | $82M | · | · | · | |
| Net Stock Activity | · | · | · | · | · | · | · | $190M | $82M | · | · | · | |
| Financing Cash Flow | $117M | $93M | $-35M | $-29M | $195M | $200M | $8M | $204M | $85M | $119.0K | · | · | |
| Net Change in Cash | $-23M | $23M | $-62M | $-248M | $7M | $269M | $-6M | $30M | $22M | $-29M | $53M | $2.0K | |
| Taxes Paid | $285.0K | $-72.0K | $-142.0K | $12M | $6M | $-191.0K | $904.0K | $3M | · | · | · | · | |
| Free Cash Flow | $-126M | $-176M | $-228M | $-238M | $135M | $-81M | $-119M | $91M | $-65M | $-57M | $-23M | · | |
| Levered FCF | · | · | $-235M | $-261M | $111M | $-82M | · | · | · | · | · | · |
Rentabilité
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -94.6% | -280.0% | -297.1% | -233.2% | 34.0% | -77.1% | -422.9% | 40.3% | -730.1% | -1423.8% | -304.9% | · | |
| Net Margin | -113.8% | -272.5% | -292.0% | -248.7% | 27.2% | -72.0% | -268.9% | 45.7% | -704.0% | -1372.1% | -300.6% | · | |
| Pretax Margin | -113.8% | -272.5% | -292.1% | -248.7% | 30.0% | -68.6% | -276.7% | 47.6% | -704.0% | -1381.6% | · | · | |
| EBITDA Margin | -94.6% | -280.0% | -297.1% | -233.2% | 34.0% | -77.1% | -422.9% | 40.3% | -730.1% | -1423.8% | -304.9% | · | |
| ROA | -42.2% | -43.7% | -37.5% | -28.8% | 14.0% | -18.4% | -18.2% | 26.9% | -39.4% | -31.9% | -20.3% | · | |
| ROE | -122.5% | -81.0% | -78.1% | -51.9% | 20.9% | -28.0% | -20.6% | 19.9% | -42.4% | -33.3% | -23.0% | · | |
| ROIC | -156.9% | · | -86.0% | -50.9% | 18.9% | -33.1% | -32.2% | 16.6% | -41.5% | -40.1% | · | · |
Liquidité et Solvabilité
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.4 | 2.7 | 2.6 | 3.2 | 4.0 | 6.5 | 10.2 | 15.2 | 11.6 | 9.7 | 27.2 | · | |
| Quick Ratio | 2.2 | 2.5 | 2.3 | 3.0 | 3.8 | 6.4 | 8.8 | 14.4 | 11.1 | 9.3 | 26.8 | · | |
| Interest Coverage | · | · | -39.1 | -11.3 | 6.1 | -154.6 | · | · | · | · | -1156.8 | · |
Efficacité
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.4 | 0.2 | 0.1 | 0.1 | 0.5 | 0.3 | 0.1 | 0.6 | 0.1 | 0.0 | 0.1 | · | |
| Receivables Turnover | 7.3 | 3.7 | 3.4 | 3.7 | 12.5 | 3.8 | · | · | · | · | 5.2 | · |
Par action
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $2.02 | $5.24 | $7.08 | $11.92 | $17.84 | $10.08 | $12.17 | $14.09 | $5.85 | $6.11 | $8.24 | · | |
| Revenue / Share | $3.30 | $1.68 | $2.06 | $2.61 | $10.71 | $4.15 | $0.96 | $5.96 | · | · | · | · | |
| Cash Flow / Share | $-2.40 | $-3.50 | $-4.99 | $-4.81 | $4.98 | $-1.45 | $-2.94 | $2.86 | · | · | · | · | |
| Cash / Share | $0.68 | $1.16 | $0.78 | $2.24 | $8.06 | $9.03 | $1.88 | $2.09 | $1.49 | $0.94 | $2.06 | · | |
| EPS (TTM) | $-3.76 | $-4.59 | $-6.02 | $-6.50 | $2.91 | $-2.98 | $-2.58 | $2.73 | $-2.45 | $-2.38 | · | · |
Taux de croissance
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 104.5% | -7.7% | -19.9% | -76.0% | 204.3% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 14.8% | -43.8% | -16.4% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 2.0% | · | · | · | · | · | · | · | · | · | · | · |
Valorisation (TTM)
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $170M | $83M | $90M | $113M | $470M | $155M | $35M | $219M | $10M | $5M | $8M | · | |
| Net Income TTM | $-194M | $-227M | $-263M | $-280M | $128M | $-111M | $-95M | $100M | $-73M | $-63M | $-23M | · | |
| Market Cap | $733M | $383M | $791M | $982M | $1.40B | $1.70B | $1.52B | $1.52B | $1.04B | $491M | $437M | · | |
| P/E | -3.8 | -1.7 | -3.0 | -3.5 | 11.2 | -15.2 | -15.9 | 15.4 | -13.6 | -7.8 | · | · | |
| P/S | 4.3 | 4.6 | 8.8 | 8.7 | 3.0 | 11.0 | 43.0 | 6.9 | 100.1 | 107.0 | 57.6 | · | |
| P/B | 7.1 | 1.5 | 2.5 | 1.9 | 1.8 | 4.5 | 3.4 | 3.0 | 5.7 | 3.0 | 2.0 | · | |
| P / Tangible Book | 7.1 | 1.5 | 2.5 | 1.9 | 1.8 | 4.5 | · | · | · | · | · | · | |
| P / Cash Flow | -5.9 | -2.2 | -3.6 | -4.7 | 6.4 | -31.4 | -14.1 | 14.5 | -17.9 | -10.1 | -19.4 | · | |
| P / FCF | -5.8 | -2.2 | -3.5 | -4.1 | 10.4 | -21.0 | -12.7 | 16.6 | -16.0 | -8.7 | -19.0 | · | |
| Earnings Yield | -26.1% | -59.4% | -33.5% | -28.7% | 8.9% | -6.6% | -6.3% | 6.5% | -7.4% | -12.8% | · | · |
Compte de résultat
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $108M | $6M | $30M | $30M | $21M | $89M | $21M | $24M | $22M | $16M | $29M | $20M | $19M | $31M | $27M | $33M | |
| Cost of Revenue | · | · | · | · | · | · | · | $12M | $11M | $4M | $12M | $9M | $4M | $13M | $13M | $13M | |
| R&D Expense | $56M | $57M | $60M | $56M | $60M | $53M | $50M | $54M | $49M | $55M | $58M | $60M | $59M | $63M | $63M | $61M | |
| SG&A Expense | $22M | $21M | $22M | $20M | $20M | $20M | $20M | $19M | $19M | $18M | $23M | $24M | $23M | $21M | $21M | $21M | |
| Operating Expenses | $79M | $90M | $88M | $82M | $85M | $77M | $73M | $86M | $78M | $79M | $94M | $93M | $85M | $89M | $98M | $95M | |
| Operating Income | $29M | $-83M | $-58M | $-52M | $-63M | $12M | $-51M | $-62M | $-56M | $-64M | $-65M | $-73M | $-66M | $-58M | $-71M | $-63M | |
| Interest Expense | · | · | · | · | · | · | · | · | $449.0K | $2M | $2M | $1M | $3M | · | $6M | $7M | |
| Interest Income | $1M | $2M | $3M | $4M | $3M | $2M | $3M | $3M | $4M | $2M | · | · | · | · | · | · | |
| Other Non-op | $-7M | $-7M | $-10M | $-10M | $-8M | $-6M | $182.0K | $2M | $3M | $533.0K | $3M | $1M | $-519.0K | $-2M | $-4M | $-6M | |
| Pretax Income | · | · | · | · | · | · | · | · | · | · | $-62M | $-72M | $-67M | $-60M | $-75M | $-68M | |
| Income Tax | · | · | · | · | · | · | · | · | · | · | · | · | · | $-43.0K | $0 | $0 | |
| Net Income | $23M | $-90M | $-67M | $-62M | $-71M | $6M | $-51M | $-60M | $-53M | $-63M | $-62M | $-72M | $-67M | $-60M | $-75M | $-68M | |
| EPS (Basic) | $0.43 | $-1.72 | $-1.30 | $-1.20 | $-1.38 | $0.12 | $-0.99 | $-1.17 | $-1.05 | $-1.38 | $-1.41 | $-1.66 | $-1.53 | $-1.38 | $-1.75 | $-1.58 | |
| EPS (Diluted) | $0.43 | $-1.72 | $-1.30 | $-1.20 | $-1.38 | $0.12 | $-0.99 | $-1.17 | $-1.05 | $-1.38 | $-1.41 | $-1.66 | $-1.53 | $-1.38 | $-1.75 | $-1.58 | |
| Shares (Basic) | 52,820,000 | 52,428,000 | · | 51,689,000 | 51,483,000 | 51,362,000 | · | 50,800,000 | 50,601,000 | 45,733,000 | 43,945,000 | 43,531,000 | 43,451,000 | · | 43,251 | 43,111 | |
| Shares (Diluted) | 53,016,000 | 52,428,000 | · | 51,689,000 | 51,483,000 | 51,434,000 | · | 50,800,000 | 50,601,000 | 45,733,000 | 43,945,000 | 43,531,000 | 43,451,000 | · | 43,251 | 43,111 | |
| EBITDA | $29M | $-83M | · | $-52M | $-63M | $12M | · | $-62M | $-56M | $-64M | $-65M | $-73M | $-66M | · | $-71M | $-63M |
Bilan
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $36M | $15M | $34M | $59M | $80M | $130M | $58M | $57M | $58M | $113M | $53M | $69M | $70M | $97M | $119M | $121M | |
| Short-term Investments | $69M | $135M | $196M | $215M | $244M | $138M | $177M | $199M | $233M | $226M | $249M | $251M | $262M | · | $264M | $282M | |
| Receivables | $107M | $10M | $26M | $25M | $20M | $18M | $20M | $24M | $23M | $16M | $28M | $21M | $19M | · | $33M | $38M | |
| Prepaid Expense | $12M | $12M | $12M | $13M | $11M | $11M | $9M | $11M | $10M | $14M | $13M | $15M | $16M | · | $15M | $16M | |
| Other Current Assets | $12M | $14M | $13M | $19M | $19M | $16M | $14M | $23M | $23M | $27M | $23M | $22M | $23M | · | $7M | $9M | |
| Current Assets | $236M | $187M | $281M | $332M | $374M | $313M | $278M | $313M | $347M | $395M | $366M | $379M | $389M | · | $437M | $465M | |
| PP&E (Net) | $98M | $102M | $105M | $108M | $111M | $114M | $118M | $121M | $124M | $128M | $136M | $139M | $142M | · | $141M | $139M | |
| PP&E (Gross) | $192M | $193M | $192M | $191M | $191M | $191M | $190M | $190M | $189M | $189M | $190M | $189M | $187M | · | $178M | $173M | |
| Accum. Depreciation | $94M | $91M | $87M | $84M | $80M | $76M | $72M | $69M | $65M | $61M | $54M | $50M | $46M | · | $37M | $34M | |
| Other Non-current Assets | $6M | $6M | $5M | $4M | $2M | $3M | $4M | $4M | $3M | $4M | $5M | $4M | $8M | · | $8M | $6M | |
| Total Assets | $387M | $342M | $453M | $525M | $581M | $491M | $466M | $519M | $569M | $629M | $634M | $682M | $748M | · | $884M | $953M | |
| Accounts Payable | $16M | $21M | $21M | $22M | $22M | $19M | $23M | $20M | $16M | $31M | $22M | $12M | $23M | · | $25M | $17M | |
| Current Liabilities | $83M | $71M | $118M | $125M | $120M | $107M | $103M | $103M | $98M | $110M | $127M | $118M | $112M | · | $124M | $115M | |
| Capital Leases | $62M | $63M | $65M | $67M | $70M | $72M | $74M | $76M | $78M | $80M | $84M | $85M | $87M | · | $85M | $86M | |
| Other Non-current Liabilities | $486.0K | $622.0K | $638.0K | $648.0K | $664.0K | $680.0K | $4M | $4M | $4M | $3M | $6M | $6M | $6M | · | $9M | $9M | |
| Total Liabilities | $315M | $321M | $350M | $364M | $367M | $217M | $206M | $218M | $221M | $239M | $271M | $277M | $283M | · | $320M | $323M | |
| Common Stock | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $4.0K | $4.0K | $4.0K | · | $4.0K | $4.0K | |
| Retained Earnings | $-1.19B | $-1.22B | $-1.13B | $-1.06B | $-997M | $-926M | $-932M | $-881M | $-821M | $-768M | $-642M | $-580M | $-508M | · | $-382M | $-306M | |
| AOCI | $-875.0K | $-870.0K | $-687.0K | $-652.0K | $-750.0K | $-762.0K | $-741.0K | $-582.0K | $-2M | $-3M | $-7M | $-10M | $-12M | · | $-18M | $-15M | |
| Stockholders' Equity | $72M | $21M | $103M | $161M | $214M | $274M | $260M | $301M | $348M | $391M | $363M | $406M | $465M | $516M | $564M | $631M | |
| Liabilities + Equity | $387M | $342M | $453M | $525M | $581M | $491M | $466M | $519M | $569M | $629M | $634M | $682M | $748M | · | $884M | $953M | |
| Shares Outstanding | 54,164,000 | 51,617,000 | 50,892,000 | 50,619,000 | 50,389,000 | 50,117,000 | 49,549,000 | 49,534,000 | 49,317,000 | 49,043,000 | 43,991,000 | 43,621,000 | 43,465,000 | · | 43,292,000 | 43,171,000 |
Flux de trésorerie
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $3M | |
| Stock-based Comp | $9M | $9M | $8M | $9M | $9M | $9M | $10M | $10M | $9M | $10M | $10M | $11M | $11M | $9M | $10M | $10M | |
| Operating Cash Flow | $-62M | $-76M | $-52M | $-56M | $-49M | $34M | $-32M | $-41M | $-45M | $-55M | $-49M | $-47M | $-81M | $-39M | $-50M | $-62M | |
| CapEx | $760.0K | $1M | $508.0K | $491.0K | $391.0K | $1M | $1M | $326.0K | $474.0K | $557.0K | $1M | $3M | $5M | $5M | $5M | $9M | |
| Investing Cash Flow | $66M | $71M | $38M | $42M | $-140M | $45M | $40M | $50M | $-268.0K | $13M | $39M | $55M | $63M | $27M | $53M | $-1M | |
| Financing Cash Flow | $18M | $-14M | $-10M | $-7M | $139M | $-6M | $-8M | $-11M | $-9M | $121M | $-5M | $-9M | $-9M | $-9M | $-5M | $-8M | |
| Net Change in Cash | $21M | $-19M | $-24M | $-21M | $-51M | $73M | $909.0K | $-1M | $-55M | $78M | $-16M | $-1M | $-27M | $-22M | $-3M | $-70M | |
| Free Cash Flow | · | $-77M | · | · | · | $33M | · | · | · | $-56M | · | · | $-86M | · | · | · |
Rentabilité
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 27.1% | -1304.0% | · | -176.3% | -296.3% | 13.6% | · | -256.6% | -251.3% | -408.8% | -224.7% | -366.0% | -345.7% | · | -268.0% | -191.5% | |
| Net Margin | 21.0% | -1408.6% | · | -208.3% | -331.8% | 6.8% | · | -246.3% | -237.7% | -405.4% | -214.0% | -360.7% | -348.4% | · | -284.7% | -208.8% | |
| Pretax Margin | · | · | · | · | · | · | · | · | · | · | -214.0% | -360.7% | -348.4% | · | -284.7% | -208.8% | |
| EBITDA Margin | 27.1% | -1304.0% | · | -176.3% | -296.3% | 13.6% | · | -256.6% | -251.3% | -408.8% | -224.7% | -366.0% | -345.7% | · | -268.0% | -191.5% | |
| ROA | 4.7% | -21.6% | · | -11.9% | -12.3% | 1.1% | · | -10.3% | -8.5% | -9.2% | -8.2% | -8.8% | -7.5% | · | -9.0% | -7.6% | |
| ROE | 15.9% | -61.0% | · | -26.8% | -25.2% | 1.8% | · | -17.9% | -14.1% | -14.8% | -13.4% | -13.9% | -11.6% | · | -14.7% | -12.0% |
Liquidité et Solvabilité
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.9 | 2.6 | · | 2.7 | 3.1 | 2.9 | · | 3.1 | 3.5 | 3.6 | 2.9 | 3.2 | 3.5 | · | 3.5 | 4.1 | |
| Quick Ratio | 2.6 | 2.3 | · | 2.4 | 2.9 | 2.7 | · | 2.7 | 3.2 | 3.2 | 2.6 | 2.9 | 3.1 | · | 3.4 | 3.8 | |
| Interest Coverage | · | · | · | · | · | · | · | · | -124.8 | -32.4 | -40.0 | -65.3 | -24.0 | · | -11.9 | -9.1 |
Efficacité
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.0 | · | 0.1 | 0.0 | 0.2 | · | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | |
| Receivables Turnover | 1.7 | 0.5 | · | 1.2 | 1.0 | 5.2 | · | 0.9 | 1.0 | 0.9 | 1.0 | 0.7 | 0.8 | · | 0.7 | 0.8 |
Par action
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.32 | $0.41 | · | $3.19 | $4.24 | $5.47 | · | $6.08 | $7.06 | $7.97 | $8.25 | $9.30 | $10.70 | · | $13.02 | $14.61 | |
| Revenue / Share | $2.04 | $0.12 | · | $0.58 | $0.41 | $1.73 | · | $0.48 | $0.44 | $0.34 | $657.96 | $458.91 | $440.45 | · | $612.98 | $757.32 | |
| Cash Flow / Share | · | $-1.45 | · | · | · | $0.65 | · | · | · | $-1.21 | · | · | $-1862.28 | · | · | · | |
| Cash / Share | $0.67 | $0.29 | · | $1.16 | $1.58 | $2.60 | · | $1.14 | $1.17 | $2.30 | $1.21 | $1.57 | $1.61 | · | $2.74 | $2.81 | |
| EPS (TTM) | $-3.79 | $-5.60 | · | $-3.45 | $-3.42 | $-3.09 | · | · | · | · | $-5.98 | $-6.32 | $-6.24 | · | $1.72 | $2.10 |
Valorisation (TTM)
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $174M | $88M | · | $161M | $156M | $157M | · | · | · | · | $99M | $97M | $110M | · | $480M | $484M | |
| Net Income TTM | $-196M | $-290M | · | $-178M | $-176M | $-158M | · | · | · | · | $-261M | $-274M | $-270M | · | $74M | $91M | |
| Market Cap | $649M | $433M | · | $488M | $414M | $358M | · | $520M | $577M | $1.03B | $724M | $872M | $822M | · | $1.14B | $1.07B | |
| P/E | -3.2 | -1.5 | · | -2.8 | -2.4 | -2.3 | · | · | · | · | -2.8 | -3.2 | -3.0 | · | 15.4 | 11.8 | |
| P/S | 3.7 | 4.9 | · | 3.0 | 2.7 | 2.3 | · | · | · | · | 7.3 | 9.0 | 7.5 | · | 2.4 | 2.2 | |
| P/B | 9.0 | 20.5 | · | 3.0 | 1.9 | 1.3 | · | 1.7 | 1.7 | 2.6 | 2.0 | 2.1 | 1.8 | · | 2.0 | 1.7 | |
| P / Tangible Book | 9.0 | 20.5 | · | 3.0 | 1.9 | 1.3 | · | 1.7 | 1.7 | 2.6 | 2.0 | 2.1 | 1.8 | · | 2.0 | 1.7 | |
| P / Cash Flow | · | -5.7 | · | · | · | 10.7 | · | · | · | -18.6 | · | · | -10.2 | · | · | · | |
| Earnings Yield | -31.6% | -66.8% | · | -35.8% | -41.7% | -43.2% | · | · | · | · | -36.3% | -31.6% | -33.0% | · | 6.5% | 8.5% |
Période la plus récente à gauche · valeurs nulles affichées comme ·
États financiers Compte de résultat, bilan, flux de trésorerie — annuel, sur les 5 dernières années
| Métrique | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Revenu | $170M | $83M | $90M | $113M | $470M |
| Marge d'exploitation % | -94.6% | -280.0% | -297.1% | -233.2% | 34.0% |
| Résultat net | $-194M | $-227M | $-263M | $-280M | $128M |
| BPA dilué | $-3.76 | $-4.59 | $-6.02 | $-6.50 | $2.91 |
| Métrique | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Ratio de liquidité | 2.4 | 2.7 | 2.6 | 3.2 | 4.0 |
| Ratio de liquidité réduite | 2.2 | 2.5 | 2.3 | 3.0 | 3.8 |
| Métrique | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Flux de trésorerie libre | $-126M | $-176M | $-228M | $-238M | $135M |
Détenteurs institutionnels (13F) 188 déclarants · $564.6M total · Au 30 septembre 2026
Institutions qui déclarent détenir cette action dans leur Formulaire SEC 13F trimestriel. Uniquement les positions longues ; un même déclarant peut apparaître deux fois pour des jambes d'options distinctes. Les jambes put/call compensatoires importantes reflètent généralement la tenue de marché ou un inventaire couvert, pas une conviction directionnelle.
Détenteurs
188
Valeur détenue
$564.6M
Nouvelles positions
27
Positions clôturées
31
Activité institutionnelle — Q2 2026 vs trimestre précédent
| Nouvelles positions | Positions clôturées | Augmenté | Diminué | Variation nette des actions |
|---|---|---|---|---|
| 27 (-14 vs T. préc.) | 31 (+5 vs T. préc.) | 65 (+3 vs T. préc.) | 55 (+1 vs T. préc.) | +67K |
Comparé à Q1 2026. Les dépôts de formulaire 13F de la SEC sont dus dans les 45 jours suivant la fin du trimestre, plus une courte période tampon pour les déposants tardifs — les trimestres encore dans cette fenêtre sont ignorés au profit de la paire la plus récente entièrement déclarée.
| Institution | Valeur | Actions | % de 13F suivies | Type |
|---|---|---|---|---|
| BlackRock, Inc. | $76 641 333 | 6 397 440 | 13,57% | Actions |
| Redmile Group, LLC | $52 338 272 | 4 368 804 | 9,27% | Actions |
| VANGUARD GROUP INC | $48 587 616 | 3 374 140 | 8,61% | Actions |
| STATE STREET CORP | $35 594 653 | 2 971 173 | 6,30% | Actions |
| JPMORGAN CHASE & CO | $26 193 619 | 2 214 169 | 4,64% | Actions |
| VANGUARD CAPITAL MANAGEMENT LLC | $25 248 533 | 2 107 557 | 4,47% | Actions |
| MORGAN STANLEY | $23 399 786 | 1 953 237 | 4,14% | Actions |
| GOLDMAN SACHS GROUP INC | $17 029 007 | 1 421 453 | 3,02% | Actions |
| AQR CAPITAL MANAGEMENT LLC | $16 512 730 | 1 378 358 | 2,92% | Actions |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $16 239 537 | 1 355 554 | 2,88% | Actions |
| MARSHALL WACE, LLP | $15 393 701 | 1 284 950 | 2,73% | Actions |
| GEODE CAPITAL MANAGEMENT, LLC | $14 874 704 | 1 241 296 | 2,63% | Actions |
| Integral Health Asset Management, LLC | $9 584 000 | 800 000 | 1,70% | Actions |
| Nuveen, LLC | $8 865 511 | 740 026 | 1,57% | Actions |
| DIMENSIONAL FUND ADVISORS LP | $8 763 715 | 731 586 | 1,55% | Actions |
| D. E. Shaw & Co., Inc. | $8 539 512 | 712 814 | 1,51% | Actions |
| TWO SIGMA INVESTMENTS, LP | $8 024 300 | 669 808 | 1,42% | Actions |
| CITADEL ADVISORS LLC | $8 014 896 | 669 023 | 1,42% | Actions |
| STIFEL FINANCIAL CORP | $6 717 524 | 560 727 | 1,19% | Actions |
| BANK OF AMERICA CORP /DE/ | $6 212 169 | 518 545 | 1,10% | Actions |
| 22NW, LP | $5 903 253 | 492 759 | 1,05% | Actions |
| MILLENNIUM MANAGEMENT LLC | $5 759 529 | 480 762 | 1,02% | Actions |
| Pale Fire Capital SE | $5 585 184 | 466 209 | 0,99% | Actions |
| NORTHERN TRUST CORP | $5 053 632 | 421 839 | 0,90% | Actions |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $4 749 471 | 396 450 | 0,84% | Actions |
| LAZARD ASSET MANAGEMENT LLC | $4 437 093 | 370 375 | 0,79% | Actions |
| FMR LLC | $4 107 444 | 342 858 | 0,73% | Actions |
| VANGUARD FIDUCIARY TRUST CO | $4 039 165 | 337 159 | 0,72% | Actions |
| Quantinno Capital Management LP | $3 595 521 | 300 127 | 0,64% | Actions |
| GSK plc | $3 252 043 | 271 456 | 0,58% | Actions |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $3 173 646 | 264 912 | 0,56% | Actions |
| RENAISSANCE TECHNOLOGIES LLC | $3 075 098 | 256 686 | 0,54% | Actions |
| JANE STREET GROUP, LLC | $3 036 846 | 253 493 | 0,54% | Actions |
| UBS Group AG | $2 994 365 | 249 947 | 0,53% | Actions |
| Jump Financial, LLC | $2 871 606 | 239 700 | 0,51% | Actions |
| Hudson Bay Capital Management LP | $2 695 500 | 225 000 | 0,48% | Actions |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $2 669 144 | 222 800 | 0,47% | Option d'achat |
| ArchPoint Investors | $2 662 890 | 222 278 | 0,47% | Actions |
| Corient Private Wealth LP | $2 607 580 | 217 661 | 0,46% | Actions |
| DEUTSCHE BANK AG\ | $2 489 864 | 207 835 | 0,44% | Actions |
| Walleye Capital LLC | $2 440 637 | 203 726 | 0,43% | Actions |
| Y-Intercept (Hong Kong) Ltd | $2 174 023 | 181 471 | 0,39% | Actions |
| Assenagon Asset Management S.A. | $2 027 962 | 169 279 | 0,36% | Actions |
| Aquilo Capital Management, LLC | $1 939 809 | 271 302 | 0,34% | Actions |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $1 785 000 | 149 000 | 0,32% | Actions |
| IEQ CAPITAL, LLC | $1 694 798 | 141 469 | 0,30% | Actions |
| Bank of New York Mellon Corp | $1 607 650 | 134 194 | 0,28% | Actions |
| Invesco Ltd. | $1 603 535 | 133 851 | 0,28% | Actions |
| Russell Investments Group, Ltd. | $1 453 879 | 121 359 | 0,26% | Actions |
| Susquehanna Portfolio Strategies, LLC | $1 431 263 | 119 471 | 0,25% | Actions |
Activistes et détenteurs de 5%+ 2 participations
Investisseurs ayant déposé un Schedule 13D auprès de la SEC — détention effective supérieure à 5% avec l'intention d'influencer l'émetteur (participations activistes, campagnes pour le conseil d'administration, fusions-acquisitions). Chaque ligne montre le dernier état connu de la position du déposant.
| Déclarant | Déposé | Participation | Statut | Objectif | Dépôt |
|---|---|---|---|---|---|
| Allan M. Fox | 18 septembre 2020 | · | Dépôt initial | Investissement passif | SEC |
| The Allan M. Fox Trust (U/A/D April 21, 2015), The Allan M. Fox Revocable Trust, FoxKiser Holdings, LLC | 25 septembre 2015 | · | Dépôt initial | Investissement passif | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Initiés de la société 25 initiés · 9 dirigeants · 16 administrateurs
| Dirigeant | Rôle | Dernière activité | Actions détenues | Achats 12m | Ventes 12m | Net 12m |
|---|---|---|---|---|---|---|
| Curran Simpson | Chief Executive Officer | 1 juillet 2026 F | 338 053 | 0 | 1 | $-262 635 |
| Mitchell Chan | Chief Financial Officer | 1 septembre 2026 F | 122 815 | 0 | 0 | $0 |
| Vittal Vasista | Chief Financial Officer | 19 mars 2024 M | 246 534 | 0 | 0 | $0 |
| Craig Malzahn | Chief Technology Officer | 1 septembre 2026 F | 81 960 | 0 | 0 | $0 |
| Steve Pakola | Chief Medical Officer | 1 août 2026 F | 205 541 | 0 | 5 | $-939 970 |
| Patrick J. Christmas | Chief Strategy & Legal Officer | 1 août 2026 F | 205 968 | 0 | 0 | $0 |
| Olivier Danos | Chief Scientific Officer | 1 février 2025 F | 226 348 | 0 | 0 | $0 |
| Stephen Yoo | Chief Medical Officer | 3 décembre 2018 M | 0 | 0 | 0 | $0 |
| Faraz Ali | Chief Business Officer | 4 janvier 2017 A | · | 0 | 0 | $0 |
| Gregory A. Ciongoli | Administrateur | 25 août 2026 A | 118 035 | 2 | 0 | $949 541 |
| Jean Bennett | Administrateur | 29 mai 2026 A | 28 861 | 0 | 0 | $0 |
| Jennifer Zachary | Administrateur | 29 mai 2026 A | 31 871 | 0 | 0 | $0 |
| Alexandra Glucksmann | Administrateur | 29 mai 2026 A | 28 861 | 0 | 0 | $0 |
| Allan M. Fox | Administrateur | 29 mai 2026 A | 28 861 | 0 | 0 | $0 |
| Kenneth T. Mills | Administrateur | 29 mai 2026 A | 495 925 | 0 | 0 | $0 |
| Daniel Tasse | Administrateur | 29 mai 2026 A | 28 861 | 0 | 0 | $0 |
| David C Stump | Administrateur | 29 mai 2026 A | 28 861 | 0 | 0 | $0 |
| Argeris N Karabelas | Administrateur | 29 mai 2026 A | 28 861 | 0 | 0 | $0 |
| George V Migausky | Administrateur | 29 mai 2026 A | 28 861 | 0 | 0 | $0 |
| Daniel Abdun-Nabi | Administrateur | 4 juin 2021 A | · | 0 | 0 | $0 |
| Luke M Beshar | Administrateur | 4 juin 2021 A | 0 | 0 | 0 | $0 |
| Donald J Hayden JR | Administrateur | 29 mai 2020 A | 0 | 0 | 0 | $0 |
| Camille D Samuels | Administrateur | 1 juin 2016 A | · | 0 | 0 | $0 |
| Edgar Engleman | Administrateur | 22 septembre 2015 C | 114 108 | 0 | 0 | $0 |
| FMR LLC | · | 17 mai 2016 J | 489 880 | 0 | 0 | $0 |
Initiés issus des déclarations SEC Form 3/4/5 ; net = uniquement P/S de marché
Détention d'ETF Détenu par 27 ETFs
Le poids reflète uniquement les participations directes en actions (N-PORT) ; les fonds à effet de levier ou basés sur des dérivés peuvent détenir une exposition supplémentaire aux swaps non indiquée.
| Fonds | Poids | Unités | Au | Source |
|---|---|---|---|---|
| BBC · ETFis Series Trust I | 0,97% | 46 670 NS | 31 juillet 2026 | N-PORT |
| IBRN · iShares Trust | 0,42% | 3 665 SH | 11 septembre 2026 | Quotidien |
| HAPS · Harbor ETF Trust | 0,19% | 33 948 NS | 31 juillet 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,13% | 66 560 NS | 31 juillet 2026 | N-PORT |
| IBB · iShares Trust | 0,04% | 445 369 SH | 11 septembre 2026 | Quotidien |
| PWS · Pacer Funds Trust | 0,04% | 909 NS | 31 juillet 2026 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,03% | 119 850 SH | 2 octobre 2026 | Quotidien |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,03% | 4 662 SH | 2 octobre 2026 | Quotidien |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,03% | 42 944 SH | 19 août 2026 | Quotidien |
| IWO · iShares Trust | 0,02% | 378 118 SH | 11 septembre 2026 | Quotidien |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,02% | 277 538 SH | 19 août 2026 | Quotidien |
| RSSL · Global X Funds | 0,02% | 23 065 NS | 31 juillet 2026 | N-PORT |
| IWM · iShares Trust | 0,01% | 1 247 225 SH | 11 septembre 2026 | Quotidien |
| VXF · VANGUARD INDEX FUNDS | 0,01% | 564 284 SH | 19 août 2026 | Quotidien |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,01% | 7 033 SH | 19 août 2026 | Quotidien |
| VHT · VANGUARD WORLD FUND | 0,01% | 130 035 SH | 19 août 2026 | Quotidien |
| DFAC · Dimensional ETF Trust | 0,00% | 145 383 NS | 31 juillet 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0,00% | 1 300 NS | 31 juillet 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0,00% | 4 800 NS | 31 juillet 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 4 755 NS | 31 juillet 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 101 339 SH | 11 septembre 2026 | Quotidien |
| DFUS · Dimensional ETF Trust | 0,00% | 12 166 NS | 31 juillet 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 9 524 SH | 3 septembre 2026 | Quotidien |
| DFAS · Dimensional ETF Trust | 0,00% | 2 500 NS | 31 juillet 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 1 496 139 SH | 19 août 2026 | Quotidien |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 3 625 SH | 19 août 2026 | Quotidien |
| IWN · iShares Trust | · | 73 037 SH | 11 septembre 2026 | Quotidien |
RGNX Consensus des analystes Opinions des analystes haussières et baissières, objectif de cours à 12 mois, potentiel de hausse
notation · 19 analystes
ACHAT
Objectif médian
$19.00
+155,7%
6 31,6%
Achat fort
10 52,6%
Achat
3 15,8%
Conserver
0 0,0%
Vente
0 0,0%
Vente forte
Objectif de cours à 12 mois
11 analystes · 2026-09-30Objectif moyen $23.73 +219,3%
← En dessous de tous les objectifs
Prix actuel $7.43
Bas$10.00
Moyenne$23.73
Haut$50.00
Comparaison des pairs (sous-secteur GICS) Indicateurs clés par rapport aux pairs du secteur
Base F.A., prix à la clôture de la dernière fin d'exercice de chaque société.
| Ticker | Capitalisation Boursière | P/E | Revenus Année/Année | Marge Nette | ROE | Marge Brute |
|---|---|---|---|---|---|---|
| RGNX | $733M | -3.8 | 104.5% | -113.8% | -122.5% | · |
| PROK | · | · | 1075.0% | -7725.2% | 6.9% | · |
| MNPR | · | · | · | · | · | · |
| CAPR | $1.66B | -12.8 | -11.6% | · | -51.1% | · |
| NGNE | $319M | -4.9 | · | · | -33.6% | · |
| PBYI | $300M | 9.8 | -0.91% | 13.6% | 26.5% | · |
| OVID | $212M | -4.0 | 1181.3% | -240.1% | -18.7% | · |
| ASMB | $539M | -61.8 | 153.5% | -8.5% | -5.5% | · |
| TECX | $391M | -5.2 | · | · | -27.7% | · |
| DMAC | $428M | · | · | · | -78.7% | · |
| MYGN | $575M | -1.6 | -1.6% | -44.4% | -96.8% | 69.9% |
Mes métriques Votre watchlist personnelle — lignes sélectionnées de Fondamentaux Complets
Choisissez les indicateurs qui vous importent — cliquez sur le + à côté de n'importe quelle ligne dans les Fondamentaux complets ci-dessus.
Votre sélection est enregistrée et vous suit sur tous les tickers.
Source : Dépôt SEC 10-Q le Aoû 6, 2026